869114-36-3Relevant academic research and scientific papers
Further structure-activity relationship studies on 4-((((3 S,6 S)-6-benzhydryltetrahydro-2 H -pyran-3-yl)amino)methyl)phenol: Identification of compounds with triple uptake inhibitory activity as potential antidepressant agents
Gopishetty, Bhaskar,Hazeldine, Stuart,Santra, Soumava,Johnson, Mark,Modi, Gyan,Ali, Solav,Zhen, Juan,Reith, Maarten,Dutta, Aloke
experimental part, p. 2924 - 2932 (2011/06/25)
To investigate structural alterations of the lead triple uptake inhibitor molecule, disubstituted 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino) methyl)phenol, we have carried out structure-activity relationship (SAR) studies to investigate the
Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: A proposed pharmacophore model for high-affinity inte
Zhang, Shijun,Fernandez, Fernando,Hazeldine, Stuart,Deschamps, Jeffrey,Zhen, Juan,Reith, Maarten E. A.,Dutta, Aloke K.
, p. 4239 - 4247 (2007/10/03)
In our previous report, we described a novel series of asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their enantiomers as blockers of monoamine transporters in the brain. In this report, we describe the furthe
TRI-SUBSTITUED 2-BENZHYDRYL-5-BENZLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES
-
Page/Page column 60; Sheet 10, (2008/06/13)
Novel 3,6-disubstituted pyrans, optionally with a further substituent at the 4-position, are monoamine reuptake inhibitors with activity profiles of anti- depressants.
